Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development
The importance of natural products, and especially plant secondary metabolites, for the treatment of diseases and drug development has already been obvious in medicine for several thousand years. Thus, this Special Issue of MDPI Biomedicines collects eight top articles from the field as regular full...
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2022 |
| Language: | English |
| Physical Description: | 1 electronic resource (334 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993545217904498 |
|---|---|
| ctrlnum |
(CKB)5690000000012059 (oapen)https://directory.doabooks.org/handle/20.500.12854/87430 (EXLCZ)995690000000012059 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Drašar, Pavel B. edt Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 1 electronic resource (334 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier The importance of natural products, and especially plant secondary metabolites, for the treatment of diseases and drug development has already been obvious in medicine for several thousand years. Thus, this Special Issue of MDPI Biomedicines collects eight top articles from the field as regular full papers in addition to five reviews. All of the published papers are a vibrant source of information on the therapeutic potential of plant secondary metabolites in the treatment of diseases and drug development. English Technology: general issues bicssc Chemical engineering bicssc Cannabis sativa (Cannabis) cannabinoids tetrahydrocannabinol (THC) cannabidiol (CBD) cannabinoid receptors (CB1 and CB2) Papaver somniferum (opium poppy) secondary metabolites ursolic acid NSCLC tumorsphere EGFR STAT3 MMP2 PD-L1 MAFLD tanshinone IIA phytochemical lipogenesis lipid accumulation LXRα malaria quinine chloroquine artemisinin onchocerciasis ivermectin moxidectin cancer vincristine vinblastine anabolic diabetes Duchenne muscular dystrophy β-ecdysone ecdysteroid ecdysterone Mas1 osteoporosis sarcopenia COVID-19 cardiometabolic diseases respiratory diseases natural product SARS-CoV-2 lung cancer United States Food and Drug Administration-approved drug natural remedy triterpenoid molecular ribbon Huisgen 1,3-dipolar cycloaddition amide bond multifunctional PEG3 derivative antimicrobial activity anti-HIV activity cytotoxicity supramolecular self-assembly phytocannabinoids cannabichromene thermos-TRPs TRPA1 α,α-dimethylheptyl effect betulinic acid BODIPY bevirimat cell-cycle fluorescent microscopy maturation inhibitor capsaicinoids endocannabinoidome microbiota overweight obesity food intake lipidomics metabolism alkaloids membrane fusion viral fusion inhibitor antiviral therapy curcumin cancer cells bioavailability curcumin derivatives curcumin analogues curcumin delivery systems natural product synthesis lignans inflammation NF-κB inhibition 3-0365-3881-X 3-0365-3882-8 Drašar, Pavel B. oth |
| language |
English |
| format |
eBook |
| author2 |
Drašar, Pavel B. |
| author_facet |
Drašar, Pavel B. |
| author2_variant |
p b d pb pbd |
| author2_role |
Sonstige |
| title |
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development |
| spellingShingle |
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development |
| title_full |
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development |
| title_fullStr |
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development |
| title_full_unstemmed |
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development |
| title_auth |
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development |
| title_new |
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development |
| title_sort |
therapeutic potential of plant secondary metabolites in the treatment of diseases and drug development |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2022 |
| physical |
1 electronic resource (334 p.) |
| isbn |
3-0365-3881-X 3-0365-3882-8 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT drasarpavelb therapeuticpotentialofplantsecondarymetabolitesinthetreatmentofdiseasesanddrugdevelopment |
| status_str |
n |
| ids_txt_mv |
(CKB)5690000000012059 (oapen)https://directory.doabooks.org/handle/20.500.12854/87430 (EXLCZ)995690000000012059 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1796649053039099904 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04360nam-a2201369z--4500</leader><controlfield tag="001">993545217904498</controlfield><controlfield tag="005">20231214133238.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202207s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5690000000012059</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/87430</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995690000000012059</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Drašar, Pavel B.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (334 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The importance of natural products, and especially plant secondary metabolites, for the treatment of diseases and drug development has already been obvious in medicine for several thousand years. Thus, this Special Issue of MDPI Biomedicines collects eight top articles from the field as regular full papers in addition to five reviews. All of the published papers are a vibrant source of information on the therapeutic potential of plant secondary metabolites in the treatment of diseases and drug development.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Technology: general issues</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemical engineering</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cannabis sativa (Cannabis)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cannabinoids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tetrahydrocannabinol (THC)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cannabidiol (CBD)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cannabinoid receptors (CB1 and CB2)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Papaver somniferum (opium poppy)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">secondary metabolites</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ursolic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NSCLC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumorsphere</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EGFR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">STAT3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MMP2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PD-L1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MAFLD</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tanshinone IIA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phytochemical</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipid accumulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LXRα</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">malaria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quinine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chloroquine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">artemisinin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">onchocerciasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ivermectin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">moxidectin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vincristine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vinblastine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anabolic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diabetes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Duchenne muscular dystrophy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">β-ecdysone</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ecdysteroid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ecdysterone</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mas1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">osteoporosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sarcopenia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">COVID-19</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiometabolic diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">respiratory diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">natural product</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SARS-CoV-2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lung cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">United States Food and Drug Administration-approved drug</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">natural remedy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">triterpenoid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular ribbon</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Huisgen 1,3-dipolar cycloaddition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">amide bond</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multifunctional PEG3 derivative</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-HIV activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytotoxicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">supramolecular self-assembly</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phytocannabinoids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cannabichromene</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thermos-TRPs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TRPA1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">α,α-dimethylheptyl effect</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">betulinic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BODIPY</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bevirimat</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell-cycle</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fluorescent microscopy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">maturation inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">capsaicinoids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endocannabinoidome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microbiota</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">overweight</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">obesity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">food intake</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipidomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">alkaloids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">membrane fusion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">viral fusion inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antiviral therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">curcumin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioavailability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">curcumin derivatives</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">curcumin analogues</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">curcumin delivery systems</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">natural product synthesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lignans</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NF-κB inhibition</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3881-X</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3882-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Drašar, Pavel B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:47:37 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-07-14 08:50:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337877990004498&Force_direct=true</subfield><subfield code="Z">5337877990004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337877990004498</subfield></datafield></record></collection> |